Revelation Biosciences is a biopharmaceutical company that develops and commercializes immune system therapeutics and diagnostics. The company is currently developing several therapeutic product candidates, including REVTx-99b, REVTx-200, REVTx-300, and REVDx-501, for the prevention and treatment of chronic nasal congestion, chronic organ disease, and respiratory viral infections such as SARS-CoV-2. Founded in 2020, Revelation Biosciences is based in San Diego, California.